Journal of Scientific Dentistry

Register      Login

VOLUME 13 , ISSUE 2 ( July-December, 2023 ) > List of Articles


microRNA—Does it Presage the Malignant Change of Oral Potentially Malignant Disorders: A Systematic Review

Annapoorani Sevagaperumal, Winnifred Christy

Keywords : Biomarker, microRNA, Malignancy, Oral potentially malignant disorders, Prognosis

Citation Information : Sevagaperumal A, Christy W. microRNA—Does it Presage the Malignant Change of Oral Potentially Malignant Disorders: A Systematic Review. 2023; 13 (2):55-60.

DOI: 10.5005/jp-journals-10083-1024

License: CC BY-NC 4.0

Published Online: 23-11-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Aim: The aim of this systematic review is to uncover the role of microRNAs (miRNAs) in foreseeing malignant progression in oral potentially malignant disorders (OPMD) as the need for an effective yet noninvasive independent biomarker for malignancy is the need of the hour. In recent times, numerous miRNAs have been investigated for their role. Thus, a deduction about the most effective one is needed. Materials and methods: The article search for this systematic review was done using PubMed database, proceeded to adapt preferred reporting items for systematic reviews and meta-analyses (PRISMA) and population, intervention, control, and outcomes (PICO) guidelines. Followed by an assessment of bias and quality in the included articles. Results: As a result of the search strategy, 19 articles were selected. As a result, various miRNAs and their regulation were analyzed. Conclusion: microRNAs were allied with the progression of OPMD into malignancy and also in predicting the progression and prognosis of malignant lesions. Thus, they can be used as a noninvasive independent biomarker for OPMD screening and assessing malignant lesions status.

  1. Chianeh YR, Prabhu K. Biochemical markers in saliva of patients with oral squamous cell carcinoma. Asian Pac J Trop Dis 2014;4 (Suppl. 1):S33–S40. DOI: 10.1016/S2222-1808(14)60412-6.
  2. Al-Malkey MK, Abbas AA, Khalaf NF, Mubrak IA, Jasim IA. Expression analysis of salivary microRNA-31 in oral cancer patients. Int J Curr Microbiol App Sci 2015;4(12):375–382.
  3. Bartel DP. MicroRNAs: Genomics. biogenesis, mechanism, and function. Cell 2004;116(2):281–297. DOI: 10.1016/s0092-8674(04) 00045-5.
  4. El-Sakka H, Kujan O, Farah CS. Assessing miRNAs profile expression as a risk stratification biomarker in oral potentially malignant disorders: A systematic review. Oral Oncology 2018;77:57–82. DOI: 10.1016/j.oraloncology.2017.11.021.
  5. Madhura MG, Rao RS, Patil S, Fageeh HN, Alhazmi A, Awan KH. Advanced diagnostic aids for oral cancer. Dis Mon 2020; 66(12):101034. DOI: 10.1016/j.disamonth.2020.101034.
  6. Maheswari TNU, Venugopal A, Sureshbabu NM, Ramani P. Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review. Ci Ji Yi Xue Za Zhi 2018;30(2):55–60. DOI: 10.4103/tcmj.tcmj_114_17.
  7. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007;358(1):12–17. DOI: 10.1016/j.bbrc.2007.03.201.
  8. Hung KF, Liu CJ, Chiu PC, Lin JS, Chang KW, Shih WY, et al. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncol 2016;53:42–47. DOI: 10.1016/j.oraloncology.2015.11.017.
  9. Maheshwari TNU, Nivedhitha MS, Ramani P. Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders. Braz Oral Res 2020; 34:e002. DOI: 10.1590/1807-3107bor-2020.vol34.0002.
  10. Tu HF, Lin LH, Chang KW, Cheng HW, Liu CJ. Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder, J Dent Sci 2022;17(2):659–665. DOI: 10.1016/j.jds.2021.09.020.
  11. He L, Ping F, Fan Z, Zhang C, Deng M, Cheng B, et al. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. Biomed Pharmacother 2020;121:109553. DOI: 10.1016/j.biopha.2019.109553.
  12. Faur CI, Roman RC, Jurj A, Raduly L, Almăşan O, Rotaru H, et al. Salivary exosomal MicroRNA-486-5p and MicroRNA-10b-5p in oral and oropharyngeal squamous cell carcinoma. Medicina (Kaunas) 2022;58(10):1478. DOI: 10.3390/medicina58101478.
  13. Heravi FM, Trachtenberg AJ, Kuo WP, Cheng YS. Genomewide study of salivary microRNAs for detection of oral cancer. J Dent Res 2014;93(Suppl. 7):86S–93S. DOI: 10.1177/0022034514531018.
  14. Yang CC, Hung PS, Wang PW, Liu CJ, Chu TH, Cheng HW, et al. miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med 2011;40(5):397–404. DOI: 10.1111/j.1600-0714.2010.01003.x.
  15. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15(17): 5473–5477. DOI: 10.1158/1078-0432.CCR-09-0736.
  16. Gai C, Camussi F, Broccoletti R, Gambino A, Cabras M, Molinaro L, et al. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma. BMC Cancer 2018;18(1):439. DOI: 10.1186/s12885-018-4364-z.
  17. Romani C, Salviato E, Paderno A, Zanotti L, Ravaggi A, Deganello A. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Theranostics 2021;11(6):2987–2999. DOI: 10.7150/thno.45157.
  18. Tu HF, Chang KW, Lin SC, Hung WW, Ji SH, Wu HL, et al. Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed samples from oral potentially malignant disorders. J Dent Sci 2022;17(2): 688–695. DOI: 10.1016/j.jds.2021.07.010.
  19. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009;15(12):3998–4008. DOI: 10.1158/1078-0432.CCR-08-3053.
  20. Hung PS, Liu CJ, Chou CS, Kao SY, Yang CC, Chang KW, et al. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS One 2013;8(11):e79926. DOI: 10.1371/journal.pone.0079926.
  21. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009;18(24):4818–4829. DOI: 10.1093/hmg/ddp446.
  22. Yap T, Seers C, Koo K, Cheng L, Vella LJ, Hill AF, et al. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders. Oral Oncol 2019;96:113–120. DOI: 10.1016/j.oraloncology.2019.07.013.
  23. Chiu SF, Ho CH, Chen YC, Wu LW, Chen YL, Jer-Horng Wu JH, et al. Malignant transformation of oral potentially malignant disorders in Taiwan: An observational nationwide population database study. Medicine (Baltimore) 2012;100(9):e24934. DOI: 10.1097/MD. 0000000000024934.
  24. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang, K et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18(10):997–1006. DOI: 10.1038/cr.2008.282.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.